Flex Pharma (FLKS) Short Interest Ratio & Short Volume

Short interest is the volume of Flex Pharma shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 749,000 shares of FLKS short. 5.26% of Flex Pharma's shares are currently sold short. Learn More on Flex Pharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FLKS shares currently have a short interest ratio of 1.0. Learn More on Flex Pharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.26% of Flex Pharma's floating shares are currently sold short.

Flex Pharma saw a drop in short interest during the month of June. As of June 30th, there was short interest totaling 749,000 shares, a drop of 20.5% from the previous total of 942,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Flex Pharma currently has issued a total of 18,070,000 shares. Some of Flex Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Flex Pharma currently has a public float of 14,250,000 shares.

5.26% of Flex Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Flex Pharma: Eliem Therapeutics, Inc. (2.22%), 23andMe Holding Co. (6.72%), PDS Biotechnology Co. (13.04%), Werewolf Therapeutics, Inc. (2.55%), Leap Therapeutics, Inc. (2.43%), Immunic, Inc. (3.85%), Veru Inc. (8.57%), Seres Therapeutics, Inc. (10.61%), Adicet Bio, Inc. (4.16%), Journey Medical Co. (0.76%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Electronics For Imaging, Inc. ($108.67 million), OHR Pharmaceutical Inc ($968,440.00), and Flex Pharma Inc ($414,047.20). View all of the most shorted stocks.

Short selling FLKS is an investing strategy that aims to generate trading profit from Flex Pharma as its price is falling. FLKS shares are trading down $0.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Flex Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FLKS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FLKS, twice per month. The most recent reporting period available is June, 30 2019.